Deodato, Francesco
 Distribuzione geografica
Continente #
EU - Europa 5.480
NA - Nord America 5.019
AS - Asia 1.771
AF - Africa 57
SA - Sud America 17
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.362
Nazione #
US - Stati Uniti d'America 4.951
DE - Germania 2.278
SE - Svezia 1.074
CN - Cina 735
SG - Singapore 536
IT - Italia 509
UA - Ucraina 497
IE - Irlanda 269
FR - Francia 243
GB - Regno Unito 192
ID - Indonesia 171
FI - Finlandia 141
IN - India 135
RU - Federazione Russa 102
TR - Turchia 71
CA - Canada 66
CI - Costa d'Avorio 49
BE - Belgio 46
IR - Iran 32
JP - Giappone 32
CZ - Repubblica Ceca 26
HK - Hong Kong 22
NL - Olanda 21
VN - Vietnam 16
ES - Italia 12
RO - Romania 11
CH - Svizzera 10
AU - Australia 8
LT - Lituania 8
CL - Cile 7
EG - Egitto 6
AT - Austria 5
EU - Europa 5
RS - Serbia 5
DK - Danimarca 4
GR - Grecia 4
BG - Bulgaria 3
BR - Brasile 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NO - Norvegia 3
PE - Perù 3
PH - Filippine 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
EC - Ecuador 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LU - Lussemburgo 2
MK - Macedonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SA - Arabia Saudita 2
TW - Taiwan 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
BZ - Belize 1
EE - Estonia 1
KW - Kuwait 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
NP - Nepal 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 12.362
Città #
Chandler 1.233
Singapore 425
Ashburn 373
Jacksonville 286
Dublin 266
San Mateo 258
Nanjing 179
Wilmington 171
Jakarta 169
Dearborn 160
Boston 125
Bremen 125
Nürnberg 114
Milan 110
New York 104
Woodbridge 103
Marseille 97
Ann Arbor 96
Beijing 92
Lawrence 81
Cattolica 79
Princeton 77
Izmir 68
Moscow 67
Nanchang 65
Fairfield 60
Houston 56
Redwood City 55
Rome 53
Abidjan 49
Helsinki 49
Munich 48
Brussels 46
Seattle 46
Los Angeles 39
Leawood 33
University Park 33
Zhengzhou 33
Fremont 31
Augusta 30
Kunming 30
Shenyang 30
Phoenixville 29
Toronto 29
Norwalk 28
Redmond 28
Hebei 26
Mountain View 24
Boardman 23
Jiaxing 23
Tianjin 22
Lancaster 21
North York 21
Detroit 20
Auburn Hills 19
Changsha 19
Falls Church 19
Pune 18
Cambridge 17
Hangzhou 16
Shanghai 16
Guangzhou 14
Hanoi 14
Brno 13
Chicago 13
Amsterdam 11
Andover 11
London 11
Monmouth Junction 11
Ardabil 10
Edinburgh 10
Frankfurt am Main 10
Lanzhou 10
Washington 10
Berlin 9
Hefei 9
Hong Kong 8
Kish 8
Sacramento 8
Central District 7
Indiana 7
Ningbo 7
Ottawa 7
San Francisco 7
Tokyo 7
Bari 6
Bologna 6
Florence 6
Jinan 6
Saint Paul 6
Sergii 6
Simi Valley 6
Chengdu 5
Costa Mesa 5
Latina 5
Phoenix 5
Vienna 5
Atlanta 4
Cairo 4
Duncan 4
Totale 6.373
Nome #
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 254
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 167
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 148
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 146
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 144
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 138
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 138
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 138
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 137
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 137
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 133
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 131
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 130
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 129
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 129
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 128
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 128
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 127
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 127
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 127
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 126
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 126
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 124
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 122
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 121
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 117
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 116
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 115
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 115
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 113
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 112
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 110
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 110
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 110
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 109
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 109
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 108
In Vivo Portal Dosimetry by an Ionization Chamber 107
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 104
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 104
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 103
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 102
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 100
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 100
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 99
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 99
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 97
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 96
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 96
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 96
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 94
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 94
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 93
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 93
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 92
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 92
Real time transit dosimetry for the breath-hold radiotherapy technique experience 88
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 88
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 86
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 85
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 85
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 84
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 84
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 84
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 83
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 83
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 82
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 82
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 81
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 79
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 78
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 77
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 77
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 76
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 76
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 76
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 73
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 72
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 72
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 72
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 71
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 70
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 69
Videoconferencing to enhance the integration between clinical medicine and teaching: a feasibility study 69
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 69
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 69
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 68
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 68
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 67
Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible? 66
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 66
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 66
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 65
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 65
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 65
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 63
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 61
Short course accelerated radiation therapy (SHARON) in palliative treatment of advanced solid cancer in older patients: A pooled analysis 60
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival 60
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 59
Totale 9.899
Categoria #
all - tutte 53.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.430


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.063 0 0 0 0 142 146 167 53 146 95 213 101
2020/2021948 34 98 16 94 139 44 108 27 128 70 155 35
2021/20221.513 139 87 21 107 119 51 25 224 58 116 283 283
2022/20233.480 472 477 243 584 207 404 189 277 394 41 144 48
2023/20241.424 66 422 57 110 38 158 92 118 13 44 193 113
2024/2025755 73 80 208 112 282 0 0 0 0 0 0 0
Totale 12.527